Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Molecular Computing Elements: Gates and Flip-Flops

  • Read more about Molecular Computing Elements: Gates and Flip-Flops
Patent Cooperation Treaty
PCT/US1999/003469
Filed on 1999-02-17

OLIGONUCLEOTIDES WHICH SPECIFICALLY BIND RETROVIRAL NUCLEOCAPSID PROTEINS

  • Read more about OLIGONUCLEOTIDES WHICH SPECIFICALLY BIND RETROVIRAL NUCLEOCAPSID PROTEINS
US Patent 6,316,190
Filed on 1999-07-12

G-PROTEIN COUPLED RECEPTOR ANTAGONISTS

  • Read more about G-PROTEIN COUPLED RECEPTOR ANTAGONISTS
Patent Cooperation Treaty
PCT/US1999/004438
Filed on 1999-02-26

MURINE INTRACISTERNAL A PARTICLE CONSTITUTIVE TRANSPOR ELEMENTS AND USES THEREOF

  • Read more about MURINE INTRACISTERNAL A PARTICLE CONSTITUTIVE TRANSPOR ELEMENTS AND USES THEREOF
Patent Cooperation Treaty
PCT/US1998/027792
Filed on 1998-12-29

Nucleic Acid Sequences of Hemoglobin-Response Genes in Candida Albicans and the Use of Reagents Derived from These Sequences In the Diagnosis of Disseminated Cadida Albicans Infections

  • Read more about Nucleic Acid Sequences of Hemoglobin-Response Genes in Candida Albicans and the Use of Reagents Derived from These Sequences In the Diagnosis of Disseminated Cadida Albicans Infections
US Patent 6,875,855
Filed on 1999-02-26

INHIBITION OF PRO HGF/SF CLEAVAGE/ACTIVATION BY SURAMIN AND OTHER RELA SMALL MOLECULES

  • Read more about INHIBITION OF PRO HGF/SF CLEAVAGE/ACTIVATION BY SURAMIN AND OTHER RELA SMALL MOLECULES
Patent Cooperation Treaty
PCT/US1999/004336
Filed on 1999-02-26

METHODS AND COMPOSITIONS OF CHEMOKINE-TUMOR ANTIGEN FUSION PROTEINS AS CANCER VACCINES

  • Read more about METHODS AND COMPOSITIONS OF CHEMOKINE-TUMOR ANTIGEN FUSION PROTEINS AS CANCER VACCINES
Patent Cooperation Treaty
PCT/US1999/005345
Filed on 1999-03-12

Therapeutic Blockage of Icer Synthesis to Prevent Icer-Mediated Inhibition of Immune Cell Activity

  • Read more about Therapeutic Blockage of Icer Synthesis to Prevent Icer-Mediated Inhibition of Immune Cell Activity
Patent Cooperation Treaty
PCT/US1999/000967
Filed on 1999-01-15

Disubstituted Lavendustin A Analogs and Pharmaceutical Composition Comprising the analogs

  • Read more about Disubstituted Lavendustin A Analogs and Pharmaceutical Composition Comprising the analogs
Patent Cooperation Treaty
PCT/US1999/004002
Filed on 1999-02-24

METHOD FOR DETECTING CANCER CELLS (AS AMENDED)

  • Read more about METHOD FOR DETECTING CANCER CELLS (AS AMENDED)
US Patent 6,232,086
Filed on 1999-01-20

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1526
  • Page 1527
  • Page 1528
  • Page 1529
  • Page 1530
  • Page 1531
  • Page 1532
  • Page 1533
  • Page 1534
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health